Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcohol extract of dehulled adlay seeds is a botanical extract developed by Joben Bio Medical, derived from the seeds of *Coix lacryma-jobi* L. var. *ma-yuen* Stapf (Adlay). This specific extract is produced using alcohol from seeds that have had their outer hulls removed. It is currently being investigated in preclinical studies for its potential therapeutic applications in treating gastric ulcers and stomach cancer. While the precise molecular targets are not specified in company literature, adlay-derived compounds are traditionally studied for their anti-inflammatory and anti-proliferative properties within the gastrointestinal tract. The company focuses on plant-based drug research and utilizes proprietary extraction technologies to isolate bioactive components from adlay for biomedical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alcohol extract of dehulled adlay seeds.